Search results
There is a page named "Santaris Pharma" on Wikipedia
- Pantheco, Santaris developed RNA-targeted medicines using a Locked Nucleic Acid (LNA) Drug Platform and Drug Development Engine. Santaris had gained...22 KB (2,168 words) - 16:39, 29 August 2024
represents a 38% premium over the final share closing price, as well as Santaris Pharma A/S for $450 million. In December 2014, the company acquired next-generation...57 KB (5,180 words) - 21:47, 26 September 2024
experimental drug for the treatment of hepatitis C, being developed by Santaris Pharma. As of 2017 it was in Phase II clinical trials. Miravirsen had been...5 KB (278 words) - 11:01, 12 June 2024
Nordisk LEO Pharma Coloplast Dansac (owner Hollister Inc) Novozymes Pharma Nord Pharmacosmos ALK-Abelló Genmab RosePharma Santaris Pharma A/S Veloxis...103 KB (10,243 words) - 13:20, 20 September 2024
Response in these HepG2 cells with stably expressing miR-122. As of 2017, Santaris Pharma was developing miravirsen, a locked nucleic acid-based antisense oligonucleotide...48 KB (5,465 words) - 08:38, 12 July 2024- E. Massengill (1898–2011) Salix (1989–2015) Sanofi Pasteur (2004–2016) Santaris (2003–2023) Schering AG (1851–2006) Schering-Plough (1971–2009) Scioderm...34 KB (2,175 words) - 05:58, 20 September 2024
